ArticleOncotarget2017

The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients.

Claudia Schubert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.